UNH stock forecast May 2025 sees OptumRx revenue growth of 9%, driven by increased specialty pharmacy utilization and consolidation benefits. Heading into the earnings release, analysts had a consensus “Moderate Buy” rating on UNH shares with the mean target of about $355 indicating potential upside of more than 30% from here. UNH executives are stacking company shares . On May 16, Hemsley bought $25 million worth of UNH stock, locking in 86,700 shares at an average price of $288.57 each. Additionally, company CFO John Rex and Director Kristen Gill were substantial UNH share buyers on May 16, 2025. UnitedHealth Group’s May 2025 forecast models anticipate operating margin resilience against rising medical loss ratios from seasonal care patterns.